---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-25-022358"
form_type: "8-K"
ticker: "VXRT"
cik: "0000072444"
company_name: "Vaxart, Inc."
filed_at: "2025-07-08T23:59:59+00:00"
generated_at: "2026-05-18T09:13:01.280464+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Vaxart delisted from Nasdaq, begins trading on OTCQX after bid price failure

## Summary
- Nasdaq delisted VXRT for non-compliance with minimum bid price requirement (Rule 5550(a)(2)).
- Trading suspended on Nasdaq July 8, 2025; stock began same-day trading on OTCQX Best Market under same ticker.
- Vaxart appealed the delisting on July 3, 2025; shares remain suspended on Nasdaq pending hearing panel decision.
- CEO Steven Lo says focus remains on advancing oral pill vaccine pipeline while considering listing options.

## SEC filing metadata
- accession: 0001437749-25-022358
- form_type: 8-K
- ticker: VXRT
- cik: 0000072444
- company_name: Vaxart, Inc.
- filed_at: 2025-07-08T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/72444/000143774925022358/0001437749-25-022358-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/72444/000143774925022358/vxrt20250708_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-25-022358
- JSON: https://secwatch.observer/filing/0001437749-25-022358.json
- Plain text: https://secwatch.observer/filing/0001437749-25-022358.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.